טוען...
Adjuvant radioactive iodine use among differentiated thyroid cancer patients in the Military Health System
BACKGROUND: Adjuvant radioactive iodine (RAI) for the treatment of differentiated thyroid cancer (DTC) has been associated with better prognosis, but, as of yet, no consensus has been reached on the best practices for RAI and data on the factors associated with its use are limited. Use of RAI and fa...
שמור ב:
| הוצא לאור ב: | Mil Med |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5727906/ https://ncbi.nlm.nih.gov/pubmed/25181724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7205/MILMED-D-13-00540 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|